Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials

Amyotrophic lateral sclerosis/motor neuron disease is a severe neurodegenerative disease characterized by upper and lower motor neuron degeneration for which there is no truly effective treatment. Several therapies have shown promise in preclinical models of motor neuron disease; however, most of th...

Full description

Bibliographic Details
Main Authors: Albert C. Ludolph, Sarah Jesse
Format: Article
Language:English
Published: SAGE Publishing 2009-09-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756285609336399
id doaj-e42c5d70fcdb4bb1b3e9265ee675e1a0
record_format Article
spelling doaj-e42c5d70fcdb4bb1b3e9265ee675e1a02020-11-25T03:34:45ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28562009-09-01210.1177/1756285609336399Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trialsAlbert C. LudolphSarah JesseAmyotrophic lateral sclerosis/motor neuron disease is a severe neurodegenerative disease characterized by upper and lower motor neuron degeneration for which there is no truly effective treatment. Several therapies have shown promise in preclinical models of motor neuron disease; however, most of them failed in human studies, so that the noticeable progress in understanding the cellular mechanisms of motor neuron degeneration has not been matched with the development of therapeutic strategies to prevent disease progression or to extend survival longer than achieved by riluzole. We review treatment development in motor neuron disease and discuss the strengths and limitations of past as well as upcoming clinical trials.https://doi.org/10.1177/1756285609336399
collection DOAJ
language English
format Article
sources DOAJ
author Albert C. Ludolph
Sarah Jesse
spellingShingle Albert C. Ludolph
Sarah Jesse
Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
Therapeutic Advances in Neurological Disorders
author_facet Albert C. Ludolph
Sarah Jesse
author_sort Albert C. Ludolph
title Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
title_short Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
title_full Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
title_fullStr Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
title_full_unstemmed Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
title_sort review: evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
publisher SAGE Publishing
series Therapeutic Advances in Neurological Disorders
issn 1756-2856
publishDate 2009-09-01
description Amyotrophic lateral sclerosis/motor neuron disease is a severe neurodegenerative disease characterized by upper and lower motor neuron degeneration for which there is no truly effective treatment. Several therapies have shown promise in preclinical models of motor neuron disease; however, most of them failed in human studies, so that the noticeable progress in understanding the cellular mechanisms of motor neuron degeneration has not been matched with the development of therapeutic strategies to prevent disease progression or to extend survival longer than achieved by riluzole. We review treatment development in motor neuron disease and discuss the strengths and limitations of past as well as upcoming clinical trials.
url https://doi.org/10.1177/1756285609336399
work_keys_str_mv AT albertcludolph reviewevidencebaseddrugtreatmentinamyotrophiclateralsclerosisandupcomingclinicaltrials
AT sarahjesse reviewevidencebaseddrugtreatmentinamyotrophiclateralsclerosisandupcomingclinicaltrials
_version_ 1724557709683982336